title: [Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary].
abstract: This paper introduces some comments on the complete text of Good Pharmacovigilance Publishing Practices, which forms appendix number 2 of the Good Pharmacovigilance Practices now published by the French Drug Agency, as was Good Clinical Practices. Each good practice is printed in italic and presented in a frame; the following comments are designed to facilitate its application. The technical terms that are used in this text are presented according to the glossary in Good Pharmacovigilance Practices.
authors.forename: M
authors.initials: M
authors.lastname: Auriche
authors.forename: P
authors.initials: P
authors.lastname: Bertrand
authors.forename: N
authors.initials: N
authors.lastname: Blay
authors.forename: G
authors.initials: G
authors.lastname: Danan
authors.forename: J D
authors.initials: JD
authors.lastname: Hamel
authors.forename: J L
authors.initials: JL
authors.lastname: Imbs
authors.forename: G
authors.initials: G
authors.lastname: Lagier
authors.forename: A
authors.initials: A
authors.lastname: Micaleff
authors.forename: N
authors.initials: N
authors.lastname: Moore
authors.forename: M
authors.initials: M
authors.lastname: Ollagnier
authors.forename: S
authors.initials: S
authors.lastname: Reveilleau-Richard
authors.forename: C
authors.initials: C
authors.lastname: Soubrié
authors.forename: F
authors.initials: F
authors.lastname: Weber
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D005602:France; D010506:Periodicals as Topic; D011358:Product Surveillance, Postmarketing
vernacular_title: Les bonnes pratiques de publication de cas cliniques de pharmacovigilance: commentaires. Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentaires.